 |
Articles: Pharmacoeconomics |
Prior Articles
Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
BMC Pregnancy and Childbirth, 06/22/09
Free full text
Use and cost of erythropoiesis-stimulating agents in patients with cancer
Current Medical Research and Opinion, 06/19/09 Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: Administrative claims analysis
Current Medical Research and Opinion, 06/19/09 Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries
Current Medical Research and Opinion, 06/19/09
Exclusive Author Commentary The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use
Respiratory Medicine, 06/19/09 Cost-Related Antibiotic Dosage Omissions-Challenge for Orbital Cellulitis Management in Resource Poor Communities
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 06/19/09 Global Economic and Health Benefits of Tobacco Control: Part 2
Clinical Pharmacology & Therapeutics, 06/18/09 Global Economic and Health Benefits of Tobacco Control: Part 1
Clinical Pharmacology & Therapeutics, 06/18/09 The precautionary principle: what is the risk of reusing disposable drops in routine ophthalmology consultations and what are the costs of reducing this risk to zero
Eye, 06/17/09 Cost-effectiveness of Intensive Lipid Lowering Therapy with 80mg of Atorvastatin, Versus 10mg of Atorvastatin, for Secondary Prevention of Cardiovascular Disease in Canada
Canadian Journal of Clinical Pharmacology, 06/17/09 Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain
Current Medical Research and Opinion, 06/17/09 An economic analysis of rotavirus vaccination in Italy
Vaccine, 06/12/09 Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
The European Journal of Health Economics, 06/11/09 Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective
PharmacoEconomics, 06/10/09 Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder: Results from the MATRIX Study
PharmacoEconomics, 06/09/09 Reviewing the Cost Effectiveness of Rotavirus Vaccination: The Importance of Uncertainty in the Choice of Data Sources
PharmacoEconomics, 06/08/09 Willingness to Pay for Cancer Prevention
PharmacoEconomics, 06/05/09 Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines
PharmacoEconomics, 06/05/09
Clinical Guideline
Economic and Human Costs of Restless Legs Syndrome
PharmacoEconomics, 06/04/09 Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states
Vaccine, 06/03/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
151 Available Pages
|
|
